pubmed-article:2161219 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2161219 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:2161219 | lifeskim:mentions | umls-concept:C0031511 | lld:lifeskim |
pubmed-article:2161219 | lifeskim:mentions | umls-concept:C0085262 | lld:lifeskim |
pubmed-article:2161219 | lifeskim:mentions | umls-concept:C0026045 | lld:lifeskim |
pubmed-article:2161219 | lifeskim:mentions | umls-concept:C0033640 | lld:lifeskim |
pubmed-article:2161219 | lifeskim:mentions | umls-concept:C0069389 | lld:lifeskim |
pubmed-article:2161219 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:2161219 | lifeskim:mentions | umls-concept:C0662453 | lld:lifeskim |
pubmed-article:2161219 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:2161219 | pubmed:dateCreated | 1990-7-5 | lld:pubmed |
pubmed-article:2161219 | pubmed:abstractText | PC-12 pheochromocytoma cells contain a growth factor-sensitive protein kinase that phosphorylates microtubule associated protein 2 (MAP-2). This MAP kinase is also activated by the protein phosphatase inhibitor okadaic acid (OA). Additionally, OA potentiates the NGF-dependent activation of MAP kinase, but causes only a modest potentiation (20%) of the maximal activation observed with EGF. Since OA is a specific serine/threonine phosphatase inhibitor, these results suggest that serine/threonine phosphorylation may be involved in the hormonal regulation of MAP kinase. | lld:pubmed |
pubmed-article:2161219 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2161219 | pubmed:language | eng | lld:pubmed |
pubmed-article:2161219 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2161219 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2161219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2161219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2161219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2161219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2161219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2161219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2161219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2161219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2161219 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2161219 | pubmed:month | May | lld:pubmed |
pubmed-article:2161219 | pubmed:issn | 0006-291X | lld:pubmed |
pubmed-article:2161219 | pubmed:author | pubmed-author:MiyasakaTT | lld:pubmed |
pubmed-article:2161219 | pubmed:author | pubmed-author:SaltielA RAR | lld:pubmed |
pubmed-article:2161219 | pubmed:author | pubmed-author:MiyasakiRR | lld:pubmed |
pubmed-article:2161219 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2161219 | pubmed:day | 16 | lld:pubmed |
pubmed-article:2161219 | pubmed:volume | 168 | lld:pubmed |
pubmed-article:2161219 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2161219 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2161219 | pubmed:pagination | 1237-43 | lld:pubmed |
pubmed-article:2161219 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:meshHeading | pubmed-meshheading:2161219-... | lld:pubmed |
pubmed-article:2161219 | pubmed:year | 1990 | lld:pubmed |
pubmed-article:2161219 | pubmed:articleTitle | Okadaic acid stimulates the activity of microtubule associated protein kinase in PC-12 pheochromocytoma cells. | lld:pubmed |
pubmed-article:2161219 | pubmed:affiliation | Laboratory of Molecular Oncology, Rockefeller University, New York, New York 10021. | lld:pubmed |
pubmed-article:2161219 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2161219 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:2161219 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2161219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2161219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2161219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2161219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2161219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2161219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2161219 | lld:pubmed |